KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 26th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Mar 07, 2016 $10.60 $11.44 $10.36 $11.14 401 800
Mar 04, 2016 $10.52 $11.08 $10.10 $10.62 380 900
Mar 03, 2016 $10.46 $10.96 $10.17 $10.53 382 400
Mar 02, 2016 $9.65 $10.64 $9.65 $10.45 492 400
Mar 01, 2016 $9.09 $9.75 $8.80 $9.69 547 200
Feb 29, 2016 $9.12 $9.44 $8.98 $9.02 275 000
Feb 26, 2016 $9.18 $9.50 $9.03 $9.16 330 400
Feb 25, 2016 $9.51 $9.90 $9.00 $9.18 410 200
Feb 24, 2016 $9.50 $9.86 $8.81 $9.78 414 200
Feb 23, 2016 $10.60 $10.63 $9.58 $9.61 396 900
Feb 22, 2016 $10.32 $11.30 $10.17 $10.62 667 300
Feb 19, 2016 $9.78 $10.16 $9.35 $9.93 483 400
Feb 18, 2016 $10.65 $10.73 $9.80 $9.84 335 700
Feb 17, 2016 $10.41 $10.80 $10.01 $10.58 316 600
Feb 16, 2016 $9.82 $10.33 $9.82 $10.28 308 600
Feb 12, 2016 $9.39 $9.72 $8.94 $9.66 258 100
Feb 11, 2016 $9.00 $9.43 $8.91 $9.16 327 300
Feb 10, 2016 $9.46 $10.00 $9.36 $9.51 282 200
Feb 09, 2016 $9.11 $9.82 $8.77 $9.40 268 000
Feb 08, 2016 $10.33 $10.39 $9.20 $9.25 465 000
Feb 05, 2016 $11.44 $11.44 $10.45 $10.50 253 200
Feb 04, 2016 $10.13 $11.61 $10.08 $11.17 310 900
Feb 03, 2016 $11.06 $11.25 $9.80 $10.16 507 500
Feb 02, 2016 $11.27 $11.39 $10.75 $10.99 293 000
Feb 01, 2016 $11.08 $11.87 $10.81 $11.49 287 300
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT